A New Modified-Release Tablet Formulation of Prednisone (Lodotra) in Patients With Nocturnal Asthma

Trial Profile

A New Modified-Release Tablet Formulation of Prednisone (Lodotra) in Patients With Nocturnal Asthma

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Dec 2014

At a glance

  • Drugs Prednisone (Primary)
  • Indications Nocturnal asthma
  • Focus Therapeutic Use
  • Acronyms MONA
  • Sponsors Horizon Pharma AG
  • Most Recent Events

    • 04 Jul 2012 Planned number of patients changed from 10 to 30 as reported by European Clinical Trials Database.
    • 15 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Mar 2011 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top